000 01154pam a22003494a 4500
005 20250914133936.0
008 040601s2004 xxka b 001 0 eng
020 _a0470856165 (alk. paper)
_cRM502.50
039 9 _a200410261454
_bfarid
_c200410211411
_dlailawati
_c200410071539
_dsanusi
_c200408301054
_drapiza
_y06-01-2004
_zfaizah
060 _aQW850
090 _aQH447.G466 3
090 _aQH447
245 0 0 _aGenomics, proteomics, and vaccines /
_ceditor, Guido Grandi
260 _aHoboken, NJ :
_bJohn Wiley & Sons,
_c2004
300 _axxi, 313 p. :
_bill.
_c26 cm.
504 _aReferences : p. 299-304
650 0 _aGenomics
650 0 _aVaccines
_xBiotechnology
650 0 _aProteomics
650 2 _aGenomics
_xmethods
650 2 _aVaccines
_xChemical Synthesis
650 2 _aProteomics
_xMethods
700 1 _aGrandi, Guido
907 _a.b13387388
_b2021-05-28
_c2019-11-12
942 _c01
_n0
_kQH447.G466 3
914 _avtls003290429
990 _anms
991 _aJabatan Farmasi, KKL
991 _aJabatan Kejuruteraan Kimia & Proses
998 _ad
_al
_at
_b2004-01-06
_cm
_da
_feng
_gxxk
_y0
_z.b13387388
999 _c338066
_d338066